Drug Approval | November 09, 2023
Lupin launches Rocuronium Bromide injection in US
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
The composition of ORAAL is protected by a granted patent in India until November 2033
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Subscribe To Our Newsletter & Stay Updated
